Earningsreport

Q2/2017 6/30/2017 EPS -0.130 ZacksConsensus -0.140 ActVsEst 0.010 - Beat

VolitionRX Limited  (VNRX) 
NASDAQ:AMEX Investor Relations: ir.volitionrx.com